Previous 10 | Next 10 |
Cronos Group Inc. (CRON) Q1 2022 Earnings Conference Call May 10, 2022, 08:30 AM ET Company Participants Shayne Laidlaw - IR Mike Gorenstein - Chairman, President and CEO Bob Madore - CFO Conference Call Participants Michael Frieden - Raymond James John Zamparo - CIBC Andrew Carter - Stifel M...
Cronos Group (NASDAQ:CRON +11.1%) stock is trading higher after the company posted better-than-expected Q1 revenue, helped by rise in demand for its cannabis flower and cannabis extracts in the Israeli medical market and the Canadian adult-use market. Net revenue from rest of the world was $2...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) delivered its 2022 first-quarter business results as revenue jumped by 99% to $25 million versus last year’s $12 million for the same time period. Cronos attributed the increase to its segment in the Israeli medical marke...
Cronos Group press release (NASDAQ:CRON): Q1 GAAP EPS of -$0.09 misses by $0.02. Revenue of $25.03M (+98.5% Y/Y) beats by $1.24M. Mike Gorenstein returned as Chief Executive Officer For further details see: Cronos Group GAAP EPS of -$0.09 misses by $0.02, revenue of $25.03M beats by $1....
Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net revenue increased by 263% year-over-year to $9.1 million in Q1 2022 Increased market share in Canada and Israel in Q1 2022 Mike Gorenstein returned as Chief Executive Of...
Cronos Group (NASDAQ:CRON) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is -$0.08 and the consensus Revenue Estimate is $23.79M (+88.7% Y/Y). Over the last 1 year, CRON has beaten EPS estimates 50% of the time and has beaten...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In order to find the best stocks under $10 to buy, you should find companies that also have strong fundamentals. Transocean ( RIG ): Its order backlog of $6.1 billion provides revenue visibility. Day rates are expe...
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2022 Annual Meeting of Shareholders on Thursday, June 23, 2022, at 11:00 a.m. ET. Cronos Group will be conducting the me...
Shares of Tilray (TLRY) have lost 40% of their value over the past 30 days, despite recent signs of progress towards the federal legalization of cannabis in the US. Is now a good time to buy? Weed stocks have been volatile for months, bobbing up and down with the news flow on Congressional ef...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These three cannabis stocks are worth buying after a steep correction ahead of potential rallies as more states legalize marijuana. Tilray ( TLRY ): Revenue target of $4 billion by 2024 and a strong position in the...
News, Short Squeeze, Breakout and More Instantly...
The organizers of a new ballot initiative in North Dakota to legalize recreational cannabis submitted their petition signatures on July 5, 2024. This step sets the stage for another potential statewide vote on a matter that voters and state lawmakers have previously turned down. Steve Bakken,...